摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide | 1346253-96-0

中文名称
——
中文别名
——
英文名称
N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide
英文别名
1,3-Dimethyl-1-[2-[18-[2-[methyl(methylcarbamothioyl)amino]ethyl]-6,8,17,19-tetraoxo-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaen-7-yl]ethyl]thiourea;1,3-dimethyl-1-[2-[18-[2-[methyl(methylcarbamothioyl)amino]ethyl]-6,8,17,19-tetraoxo-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaen-7-yl]ethyl]thiourea
N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide化学式
CAS
1346253-96-0
化学式
C34H30N6O4S2
mdl
——
分子量
650.782
InChiKey
AFSNTLRIZVVHRX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    46
  • 可旋转键数:
    6
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    170
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    {Pt(diethylenetriamine)NO3}NO3 、 N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide 在 activated carbon 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以40%的产率得到[[Pt(dietylenetriamine)]2(N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide](NO3)4*2H2O
    参考文献:
    名称:
    Interactions of a Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex
    摘要:
    The interactions of a newly synthesized platinum-modified perylene derivative, compound 7 ([{Pt(dien)}(2)-(mu-4-S,S')](NO(3))(4) (then = diethylenetriamine, 4 = N,N'-bis-(1-(2-aminoethyl)-1,3-dimethylthiourea)-3,4,9,10-perylenete-tracarboxylic acid diimide), with the human telomeric repeat were studied using various model oligo(deoxy)ribonucleotides to mimic the polymorphic nature of the telomeric G-quadruplex. UV/visible spectroscopy, CD spectropolarimetry, electrospray mass spectrometry (ES-MS), and isothermal titration calorimetry (ITC) were used to demonstrate that compound 7 selectively recognizes the antiparallel form of the unimolecular telomeric G-quadruplex formed by the sequence d(TTAGGG)(4) (dG-24), to which it binds with a 2:1 stoichiometry and nanomolar affinity. Compared with telomeric DNA, the first binding event of compound 7 in titrations with the RNA quadruplex formed by r(UUAGGG)(4) (rG-24) is 1 order of magnitude weaker. Compound 7 does not induce the antiparallel G-quadruplex RNA, which invariably exists in a parallel form and dimerizes in solution. On the basis of the cumulative experimental data, two distinct mechanisms are proposed for the recognition of G-quadruplex DNA and RNA by compound 7. Potential biomedical and biochemical applications of the platinum-perylene technology are discussed.
    DOI:
    10.1021/jp207265s
  • 作为产物:
    描述:
    N,N'-bis[2-(tert-butoxycarbonylmethylamino)ethyl]-3,4,9,10-perylenetetracarboxylic diimide 在 盐酸 作用下, 以 甲醇氯仿 为溶剂, 反应 102.0h, 生成 N,N'-bis[1,3-dimethylthioureaethyl]-3,4,9,10-perylenetetracarboxylic diimide
    参考文献:
    名称:
    Interactions of a Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex
    摘要:
    The interactions of a newly synthesized platinum-modified perylene derivative, compound 7 ([{Pt(dien)}(2)-(mu-4-S,S')](NO(3))(4) (then = diethylenetriamine, 4 = N,N'-bis-(1-(2-aminoethyl)-1,3-dimethylthiourea)-3,4,9,10-perylenete-tracarboxylic acid diimide), with the human telomeric repeat were studied using various model oligo(deoxy)ribonucleotides to mimic the polymorphic nature of the telomeric G-quadruplex. UV/visible spectroscopy, CD spectropolarimetry, electrospray mass spectrometry (ES-MS), and isothermal titration calorimetry (ITC) were used to demonstrate that compound 7 selectively recognizes the antiparallel form of the unimolecular telomeric G-quadruplex formed by the sequence d(TTAGGG)(4) (dG-24), to which it binds with a 2:1 stoichiometry and nanomolar affinity. Compared with telomeric DNA, the first binding event of compound 7 in titrations with the RNA quadruplex formed by r(UUAGGG)(4) (rG-24) is 1 order of magnitude weaker. Compound 7 does not induce the antiparallel G-quadruplex RNA, which invariably exists in a parallel form and dimerizes in solution. On the basis of the cumulative experimental data, two distinct mechanisms are proposed for the recognition of G-quadruplex DNA and RNA by compound 7. Potential biomedical and biochemical applications of the platinum-perylene technology are discussed.
    DOI:
    10.1021/jp207265s
点击查看最新优质反应信息

文献信息

  • Interactions of a Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex
    作者:Lu Rao、Joshua D. Dworkin、William E. Nell、Ulrich Bierbach
    DOI:10.1021/jp207265s
    日期:2011.11.24
    The interactions of a newly synthesized platinum-modified perylene derivative, compound 7 ([Pt(dien)}(2)-(mu-4-S,S')](NO(3))(4) (then = diethylenetriamine, 4 = N,N'-bis-(1-(2-aminoethyl)-1,3-dimethylthiourea)-3,4,9,10-perylenete-tracarboxylic acid diimide), with the human telomeric repeat were studied using various model oligo(deoxy)ribonucleotides to mimic the polymorphic nature of the telomeric G-quadruplex. UV/visible spectroscopy, CD spectropolarimetry, electrospray mass spectrometry (ES-MS), and isothermal titration calorimetry (ITC) were used to demonstrate that compound 7 selectively recognizes the antiparallel form of the unimolecular telomeric G-quadruplex formed by the sequence d(TTAGGG)(4) (dG-24), to which it binds with a 2:1 stoichiometry and nanomolar affinity. Compared with telomeric DNA, the first binding event of compound 7 in titrations with the RNA quadruplex formed by r(UUAGGG)(4) (rG-24) is 1 order of magnitude weaker. Compound 7 does not induce the antiparallel G-quadruplex RNA, which invariably exists in a parallel form and dimerizes in solution. On the basis of the cumulative experimental data, two distinct mechanisms are proposed for the recognition of G-quadruplex DNA and RNA by compound 7. Potential biomedical and biochemical applications of the platinum-perylene technology are discussed.
查看更多